A Randomized Open Controlled Trial Comparing Robot Assisted Laparoscopic Hysterectomy and Abdominal Hysterectomy for Endometrial Cancer in a Fast Track Program
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endometrial Cancer
- Sponsor
- University Hospital, Linkoeping
- Enrollment
- 50
- Locations
- 2
- Primary Endpoint
- Health Related Quality of Life (HRQoL)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of the trial is to determine whether robot assisted laparoscopic hysterectomy compared with abdominal hysterectomy in a fast track program gives a faster recovery postoperatively, causes less tissue damage and less effects on the immunological system, and is health economically cost-effective.
Detailed Description
If detailed description is requested, please contact sponsor.
Investigators
Preben Kjolhede, MD, professor
Professor
University Hospital, Linkoeping
Eligibility Criteria
Inclusion Criteria
- •Over 18 years of age.
- •Scheduled to total hysterectomy + bilateral salpingooophorectomy (BSAE) and peritoneal lavage because of endometrial carcinoma, International federation of gynecology and obstetrics (FIGO) stage 1, grade 1 and 2, with diploid DNA profile (i.e. low risk profile).
- •WHO (World Health Organisation) performance status ≤
- •Proficiency in Swedish
- •Accept to participate in the study and has signed written informed consent document.
- •The operation should be considered possible to be perform laparoscopically and by laparotomy through a low transverse abdominal wall incision.
Exclusion Criteria
- •The operation is anticipated to comprise more than the hysterectomy + BSAE.
- •A midline incision is planned for the laparotomy.
- •Contraindications towards spinal anesthesia with intrathecally applied morphine.
- •Physically disabled women who cannot be expected to be mobilized in accordance to the fast track program in a way similar to what is expected from not-physically disabled women.
- •Mentally disabled women who cannot fill in the questionnaires or understand the consequences of participating in a trial.
- •Severe psychiatric disease or on medication for psychiatric disease so that the physician consider participation in the trial inappropriate.
Outcomes
Primary Outcomes
Health Related Quality of Life (HRQoL)
Time Frame: Days 0, 1, 2, 3, 4, 5, 6, 7, 14, 21, 28, 35, 42
Quality of life measured by means of the EuroQol form (EQ-5D). The EQ-5D form was completed daily during the first eight days after surgery, then once weekly for additional six weeks. The health state index has a possible range from 0 to 1 with a higher score meaning a better quality of life.
Secondary Outcomes
- Changes in Biomarkers for Tissue Damage (C-reactive Protein (hsCRP))(One week and just before surgery. Two, 24 and 48 hours postoperatively. One and six weeks after surgery.)
- Changes in Biomarkers for Tissue Damage (Creatin Kinase (CK))(One week and just before surgery. Two, 24 and 48 hours postoperatively. One and six weeks after surgery.)
- Changes in Biomarkers for Tissue Damage (White Blood Cells (WBC))(One week and just before surgery. Two, 24 and 48 hours postoperatively. One and six weeks after surgery.)
- Health Economics (With 300 Robotic Procedures Annually)(From the day of surgery until six weeks after surgery.)
- Changes in Biomarkers for Tissue Damage (Interleukin 6 (IL-6))(One week and just before surgery. Two, 24 and 48 hours postoperatively. One and six weeks after surgery.)
- Changes in Biomarkers for Tissue Damage (Cortisol)(One week and just before surgery. Two, 24 and 48 hours postoperatively. One and six weeks after surgery.)
- Health Economics (With 500 Robotic Procedures Annually)(From the day of surgery until six weeks after surgery.)